Literature DB >> 28738354

Review of Extracorporeal Membrane Oxygenation and Dialysis-Based Liver Support Devices for the Use of Nephrologists.

Tamim Hamdi1, Biff F Palmer.   

Abstract

Acute kidney injury in the intensive care unit (ICU) is a manifestation of an underlying severe illness that commonly involves other organ systems. Pulmonary, cardiac, and hepatic failures are the most prevalent. This article provides a simplified review of the technical aspects of extracorporeal cardiopulmonary and liver support devices used in the adult ICU patient, as well as a summary of the most relevant and up-to-date clinical evidence that supports their use.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Continuous renal replacement therapy; Extracorporeal membrane oxygenation; Molecular adsorbent recirculation support; Prometheus liver support device; Selective cytopheretic device; Single pass albumin dialysis

Mesh:

Year:  2017        PMID: 28738354     DOI: 10.1159/000479342

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  3 in total

1.  Providing Continuous Renal Replacement Therapy in Patients on Extracorporeal Membrane Oxygenation.

Authors:  Nithin Karakala; Luis A Juncos
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

2.  Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.

Authors:  Shao-Wei Chen; Yueh-An Lu; Cheng-Chia Lee; An-Hsun Chou; Victor Chien-Chia Wu; Su-Wei Chang; Pei-Chun Fan; Ya-Chung Tian; Feng-Chun Tsai; Chih-Hsiang Chang
Journal:  PLoS One       Date:  2019-03-13       Impact factor: 3.240

3.  Analysis of survival after initiation of continuous renal replacement therapy in patients with extracorporeal membrane oxygenation.

Authors:  George Kuo; Shao-Wei Chen; Pei-Chun Fan; Victor Chien-Chia Wu; An-Hsun Chou; Cheng-Chia Lee; Pao-Hsien Chu; Feng-Chun Tsai; Ya-Chung Tian; Chih-Hsiang Chang
Journal:  BMC Nephrol       Date:  2019-08-14       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.